CORD-19:775b90287b44353bee979abb0970a4666022f86d / 751785-751911 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"A single SAE of worsening foot bunion was reported in Group 1 HV and considered not related to study drug by the investigator.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T36506","span":{"begin":0,"end":126},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T36506","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T199","span":{"begin":0,"end":126},"obj":"Sentence"}],"attributes":[{"subj":"T199","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T3992","span":{"begin":31,"end":37},"obj":"Phenotype"}],"attributes":[{"id":"A3992","pred":"hp_id","subj":"T3992","obj":"http://purl.obolibrary.org/obo/HP_0001822"},{"subj":"T3992","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1508","span":{"begin":26,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A1508","pred":"uberon_id","subj":"T1508","obj":"http://purl.obolibrary.org/obo/UBERON_0002387"},{"subj":"T1508","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#caec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93e4"},{"id":"CORD-19-PD-HP","color":"#93ecda"},{"id":"CORD-19-PD-UBERON","color":"#ecc093"}]}]}}